HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats.

Abstract
YM175 (disodium cycloheptylaminomethylenediphosphonate monohydrate) is a new-generation bisphosphonate with stronger inhibitory activity on bone resorption than first-generation bisphosphonates. In the present study, the effect of YM175 on hypercalcemia induced in rats by single administration of either parathyroid hormone-related protein (PTHrP) or concomitant administration of PTHrP and interleukin 1beta (IL-1beta) was investigated. YM175 (0.01-1 mg/kg, i.v.) inhibited the increase in serum free calcium concentration induced by continuous administration of PTHrP alone (3 microg/rat/day, s.c., 7 days) dose-dependently. The inhibitory effect of YM175 appeared the day after administration and remained 3 days after administration. The effect of YM175 reached a maximum 2 days after administration, at which time the ED50 value of YM175 was calculated to be 0.041 mg/kg, i.v., revealing a potency approximately 50- and 10-fold stronger than those of either pamidronate or alendronate, respectively. In contrast, elcatonin (1-10 units/kg, s.c.) only transiently inhibited PTHrP-induced free calcium increase. YM175 (0.1-3 mg/kg, i.v.) also inhibited the increase in the serum free calcium concentration induced by continuous concomitant administration of both PTHrP and IL-1beta in a dose-dependent manner. These results indicated that YM175 is expected to be a useful drug for hypercalcemia associated with malignant tumors due to its efficacy and range of effect.
AuthorsK Takahashi, A Shirahata, S Fukushima, S Kokubo, K Teramura, S Usuda
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 76 Issue 2 Pg. 155-63 (Feb 1998) ISSN: 0021-5198 [Print] Japan
PMID9541278 (Publication Type: Journal Article)
Chemical References
  • Diphosphonates
  • Interleukin-1
  • Parathyroid Hormone-Related Protein
  • Proteins
  • cimadronate
Topics
  • Animals
  • Bone Resorption (prevention & control)
  • Diphosphonates (therapeutic use)
  • Hypercalcemia (complications, drug therapy)
  • Interleukin-1 (administration & dosage)
  • Male
  • Models, Biological
  • Neoplasms, Experimental (complications)
  • Parathyroid Hormone-Related Protein
  • Proteins (administration & dosage)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: